Page last updated: 2024-11-03

rabeprazole and Esophageal Varices

rabeprazole has been researched along with Esophageal Varices in 2 studies

Rabeprazole: A 4-(3-methoxypropoxy)-3-methylpyridinyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.

Research Excerpts

ExcerptRelevanceReference

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Akahoshi, T1
Kawanaka, H1
Tomikawa, M1
Saeki, H1
Uchiyama, H1
Ikeda, T1
Shirabe, K1
Hashizume, M1
Maehara, Y1
Hidaka, H1
Nakazawa, T1
Wang, G1
Kokubu, S1
Minamino, T1
Takada, J1
Tanaka, Y1
Okuwaki, Y1
Watanabe, M1
Tanabe, S1
Shibuya, A1
Koizumi, W1

Trials

2 trials available for rabeprazole and Esophageal Varices

ArticleYear
Effect of proton pomp inhibitor (PPI : Rabeprazole) on reflux esophagitis after endoscopic injection sclerotherapy (EIS), a randomized control study (24 hour-pH monitoring).
    Fukuoka igaku zasshi = Hukuoka acta medica, 2013, Volume: 104, Issue:12

    Topics: Aged; Esophageal and Gastric Varices; Esophageal pH Monitoring; Esophagitis, Peptic; Famotidine; Fem

2013
Long-term administration of PPI reduces treatment failures after esophageal variceal band ligation: a randomized, controlled trial.
    Journal of gastroenterology, 2012, Volume: 47, Issue:2

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Combined Modality Therapy; Esophageal and Gastric Var

2012